A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses-Reference-Cited by-同舟云学术

A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses

Published:2010-04 Issue:3 Volume:33 Page:250-261
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Karkada Mohan,Weir Genevieve M.,Quinton Tara,Sammatur Leeladhar,MacDonald Lisa D.,Grant Alecia,Liwski Robert,Juskevicius Ridas,Sinnathamby Gomathinayagam,Philip Ramila,Mansour Marc

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference42 articles.

1. Advances in tumour immunotherapy;King;Qjm,2008

2. Cancer vaccines: accomplishments and challenges;Pejawar-Gaddy;Crit Rev Oncol Hematol,2008

3. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy;Van der Burg;Adv Drug Deliv Rev,2006

4. Next generation of immunotherapy for melanoma;Kirkwood;J Clin Oncol,2008

5. The hallmarks of cancer;Hanahan;Cell,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy;Nanoscale;2024

2. Therapeutic vaccines for aggressive B-cell lymphoma;Leukemia & Lymphoma;2020-08-25

3. Up-to-date role of biologics in the management of respiratory syncytial virus;Expert Opinion on Biological Therapy;2020-04-17

4. Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapy;OncoImmunology;2020-01-01

5. Generation of highly activated, antigen-specific tumor-infiltrating CD8+ T cells induced by a novel T cell-targeted immunotherapy;OncoImmunology;2020-01-01